Chronic exposure of kainate and NBQX changes AMPA toxicity in hippocampal slice cultures

Neuroreport. 2001 Nov 16;12(16):3593-7. doi: 10.1097/00001756-200111160-00044.

Abstract

Receptor agonist/antagonist mediated modulation of the excitotoxic effect of AMPA was studied in organotypic hippocampal slice cultures. Treatment of developing cultures for 2 weeks with a subtoxic dose of 2 microM kainate reduced the toxicity of 3 microM AMPA, applied for 48 h with 24 h of recovery, as measured by cellular uptake of the fluorescent dye propidium iodide. In contrast long-term treatment with 0.3 microM of the AMPA/KA antagonist NBQX increased the susceptibility of the cultures to an even lower dose of 2 microM AMPA. The modulatory effects of long-term application of low doses of kainate and NBQX, have implications for the development and use of related drugs that aim to protect against glutamate receptor-mediated disturbances.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Cell Death / drug effects
  • Cell Death / physiology
  • Excitatory Amino Acid Agonists / pharmacology*
  • Excitatory Amino Acid Antagonists / pharmacology*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Kainic Acid / pharmacology*
  • Neurons / drug effects
  • Neurons / metabolism
  • Organ Culture Techniques
  • Quinoxalines / pharmacology*
  • Rats
  • Rats, Wistar
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid / toxicity*

Substances

  • Excitatory Amino Acid Agonists
  • Excitatory Amino Acid Antagonists
  • Quinoxalines
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
  • Kainic Acid